Overview
Mikako Yasuoka practices practicing medicine in Obu, Japan.
Their clinical expertise encompasses Muscle Atrophy, Rheumatoid Arthritis (RA), Severe Acute Respiratory Syndrome (SARS), and Arthritis.
They are actively involved in clinical research, co-authoring 20 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mikako Yasuoka
Is Mikako Yasuoka a top-rated expert for Muscle Atrophy?
MediFind is an objective health platform that identifies experts based on real-world data. Mikako Yasuoka is classified as an Experienced expert for Muscle Atrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mikako Yasuoka participate in research or clinical trials?
Yes. Mikako Yasuoka has published 20 articles and abstracts on conditions like Muscle Atrophy. You can view a list of Mikako Yasuoka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ArthritisYasuoka isExperienced. Learn about Arthritis.
- Muscle AtrophyYasuoka isExperienced. Learn about Muscle Atrophy.
- Rheumatoid Arthritis (RA)Yasuoka isExperienced. Learn about Rheumatoid Arthritis (RA).
- Severe Acute Respiratory Syndrome (SARS)